Rectal Diclofenac 12.5 mg Dosing in Children
The safety and effectiveness of diclofenac in pediatric patients have not been established by the FDA 1. However, based on pharmacokinetic evidence and clinical practice, a 12.5 mg rectal dose may be appropriate depending on your child's weight.
Weight-Based Dosing Recommendation
For rectal diclofenac, the recommended dose is 0.5-1 mg/kg per dose 2, 3. A 12.5 mg suppository would be appropriate for:
- Children weighing 12.5-25 kg (approximately 28-55 lbs) using the 0.5-1 mg/kg dosing range
- Most commonly appropriate for children aged 2-6 years in this weight range
Dosing Algorithm:
- If your child weighs <12.5 kg: 12.5 mg is likely too high
- If your child weighs 12.5-25 kg: 12.5 mg is appropriate (0.5-1 mg/kg range)
- If your child weighs >25 kg: 12.5 mg may be subtherapeutic
Clinical Context
Rectal diclofenac at 1 mg/kg has demonstrated superior analgesic efficacy compared to rectal acetaminophen (30-40 mg/kg) for postoperative pain in multiple pediatric studies 4, 5, 6. The rectal route provides:
- Bioavailability of approximately 35% 3
- Absorption half-life of 0.6 hours with lag time of 0.2 hours 7
- Peak concentration at approximately 50 minutes 7
- Duration of analgesia typically 6-8 hours 2, 6
Critical Safety Considerations
Absolute Contraindications:
- Avoid if your child has any bleeding disorder or thrombocytopenia - diclofenac increases bleeding risk (RR 3.06 compared to opioids) 8
- Avoid if surgery involves high bleeding risk (e.g., tonsillectomy, adenoidectomy) 8
- Avoid if your child has renal impairment 1
- Avoid if your child has active gastrointestinal disease 1
Relative Cautions:
- Dehydration: NSAIDs can impair renal function in volume-depleted children
- Concurrent NSAID use: Do not combine with other NSAIDs
- Duration: Limit to short-term use (48-72 hours maximum) for acute pain 2
Practical Guidance
Dosing frequency: Every 8 hours as needed 2
Maximum daily dose: 3 mg/kg/day (so 12.5 mg three times daily would be appropriate for a child weighing >12.5 kg)
Common pitfall: The FDA label states pediatric safety is not established 1, but this reflects lack of formal approval studies rather than evidence of harm. Extensive clinical use and pharmacokinetic data support weight-based dosing in children >1 year 3, 7, 8.
Monitoring: Watch for signs of gastrointestinal upset, bleeding (bruising, nosebleeds), or decreased urine output. If any occur, discontinue immediately.